EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Epileptic and developmental encephalopathy secondary to inversion‐duplication of chromosome 15: Description of epilepsy characteristics and therapeutic outcomes

Cristina Benítez-Provedo iD, Marta García-Fernández iD, Eva Gutiérrez-Delicado iD, Elena González-Alguacil iD, Nelmar Valentina Ortiz-Cabrera iD, Bárbara Fernández-Garoz, Juan José García Peñas iD, Nuria Lamagrande Casanova iD, María Ballarà-Petitbò iD, Anna Duat Rodríguez iD, Irene Sánchez-Miranda Román iD, Antonio Gil-Nagel Rein iD und 22 weitere

Epilepsia · 2026

DOI: 10.1002/epi.70311 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia, 2026. Verfasst von Cristina Benítez-Provedo und 33 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Service, Hospital Infantil Universitario Niño Jesús, Madrid, Spain. Hauptthemen laut MEDLINE: Epilepsy, Chromosome Inversion. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Inversion‐duplication syndrome of chromosome 15 (invdup15) is a chromosomal disorder characterized by an inverted duplication of 15q11.2‐q13.1. Epilepsy is highly prevalent (60%–80%), drug‐resistant, and may progress to developmental epileptic encephalopathies (DEEs) such as Lennox–Gastaut syndrome (LGS). Despite its impact, epilepsy and optimal treatments remain poorly described.

Methods

A retrospective multicenter study across 37 Spanish hospitals analyzed 54 patients, divided into two genetic subgroups: invdup15q and intdup15q. Clinical and genetic data were reviewed, focusing on epilepsy onset, seizure types, syndrome progression, electroencephalographic (EEG) findings, and treatment response.

Results

Epilepsy was present in 29 of 54 (54%) patients, with a mean age at onset of 7.4 years (range = 1 month–24 years, SD = 6.4). LGS (16/29, 55%) and focal epilepsy (15/29, 52%) were the most frequent epilepsy types, although infantile epileptic spasms predominated in younger patients (5/6, 83%). Late onset LGS (>8 years) occurred in 38%. Initial seizures were mostly focal motor (10/29, 34%) and generalized tonic–clonic seizures (8/29, 28%), later evolving to tonic, myoclonic, and atypical absence seizures. Twenty‐six of 29 (90%) reported drug‐resistant epilepsy. Epilepsy was more frequent (65% vs. 35%, p < .05) and had earlier onset (median = 5.7 vs. 12.3 years) in invdup15q than intdup15q. EEG demonstrated unusual activities including diffuse fast activity, along with repetitive trains of paroxysmal fast activity during sleep. The most effective antiseizure drugs were oxcarbazepine for focal (9/11, 81%) and for generalized (2/3, 67%) epilepsy and valproic acid (6/10, 60%) for generalized epilepsy, whereas vigabatrin, zonisamide, and brivaracetam showed limited efficacy. In LGS, oxcarbazepine (8/12, 66%), valproic acid (11/18, 61%), and cannabidiol (6/9, 66%) yielded the best responses. All patients had early developmental delay; autism spectrum disorder was diagnosed in 22 of 54 (41%) and behavioral disorders in 30 of 54 (56%). Significance Epilepsy in invdup15 is highly drug‐resistant and exhibits features consistent with DEEs, particularly LGS. EEG findings may serve as disorder biomarkers. Oxcarbazepine and valproic acid were the treatments most often associated with seizure improvement in this sample.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyChromosome InversionHumansChild, PreschoolChromosomes, Human, Pair 15AnticonvulsantsChildFemaleAdolescentElectroencephalographyInfantRetrospective StudiesLennox Gastaut SyndromeMaleYoung AdultTreatment Outcome

Stichwörter der Autor:innen

Lennox–Gastaut late onset syndromedrug‐resistant epilepsyepileptic and developmental encephalopathyinversion‐duplication of chromosome 15 syndrome

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Neurology Service, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Epilepsy Monitoring Unit, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • School of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
  • Clinical Genetics Unit, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Department of Neurology, Hospital Ruber Internacional, Madrid, Spain.
  • Epilepsy Program, Neurology Department, Hospital Universitario La Princesa, Madrid, Spain.

ORCID-Profile: Cristina Benítez-Provedo, Marta García-Fernández, Eva Gutiérrez-Delicado, Elena González-Alguacil, Nelmar Valentina Ortiz-Cabrera, Juan José García Peñas, Nuria Lamagrande Casanova, María Ballarà-Petitbò, Anna Duat Rodríguez, Irene Sánchez-Miranda Román, Antonio Gil-Nagel Rein, María de Toledo, Beatriz González-Giráldez, Rebeca Losada-Del Pozo, Elena Martínez-Cayuelas, María Socorro Pérez-Poyato, Eulalia Turon-Viñas, Gema Iglesias-Escalera, J M Ramos-Fernández, Ramón Cancho-Candela, Mario Urbano-Martín, María Vázquez-López, Salvador Ibáñez-Mico, Joaquín Alejandro Fernández-Ramos, Desiré González Barrios, Fernando Ferragut, Jose Antonio Antón Blasco, Cristina Castaño-De la Mota, Ana Camacho, David Conejo, Juan Pedro Navarro-Romero, Víctor Soto-Insuga

Zitieren

APA

Benítez-Provedo, C., García-Fernández, M., Gutiérrez-Delicado, E., González-Alguacil, E., Ortiz-Cabrera, N. V., Fernández-Garoz, B., García Peñas, J. J., Lamagrande Casanova, N., Ballarà-Petitbò, M., Rodríguez, A. D., Román, I. S., Gil-Nagel Rein, A., de Toledo, M., González-Giráldez, B., Losada-Del Pozo, R., Martínez-Cayuelas, E., Pérez-Poyato, M. S., Turon-Viñas, E., Iglesias-Escalera, G., …, & Soto-Insuga, V. (2026). Epileptic and developmental encephalopathy secondary to inversion‐duplication of chromosome 15: Description of epilepsy characteristics and therapeutic outcomes. Epilepsia. https://doi.org/10.1002/epi.70311

Vancouver

Benítez-Provedo C, García-Fernández M, Gutiérrez-Delicado E, González-Alguacil E, Ortiz-Cabrera NV, Fernández-Garoz B, et al. Epileptic and developmental encephalopathy secondary to inversion‐duplication of chromosome 15: Description of epilepsy characteristics and therapeutic outcomes. Epilepsia. 2026. doi:10.1002/epi.70311

BibTeX
@article{BentezProvedo2026,
  author = {Benítez-Provedo, Cristina and García-Fernández, Marta and Gutiérrez-Delicado, Eva and González-Alguacil, Elena and Ortiz-Cabrera, Nelmar Valentina and Fernández-Garoz, Bárbara and García Peñas, Juan José and Lamagrande Casanova, Nuria and Ballarà-Petitbò, María and Rodríguez, Anna Duat and Román, Irene Sánchez-Miranda and Gil-Nagel Rein, Antonio and de Toledo, María and González-Giráldez, Beatriz and Losada-Del Pozo, Rebeca and Martínez-Cayuelas, Elena and Pérez-Poyato, María Socorro and Turon-Viñas, Eulalia and Iglesias-Escalera, Gema and Ramos-Fernández, J M and Cancho-Candela, Ramón and Urbano-Martín, Mario and Vázquez-López, María and Ibáñez-Mico, Salvador and Fernández-Ramos, Joaquín Alejandro and Barrios, Desiré González and Ferragut, Fernando and Blasco, Jose Antonio Antón and la Mota, Cristina Castaño-De and Gonzalez-Santiago, Pilar and Camacho, Ana and Conejo, David and Navarro-Romero, Juan Pedro and Soto-Insuga, Víctor},
  title = {Epileptic and developmental encephalopathy secondary to inversion‐duplication of chromosome 15: Description of epilepsy characteristics and therapeutic outcomes},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70311}
}
Kostenlos starten →